These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 37841256)

  • 1. Advances in the implications of the gut microbiota on the treatment efficacy of disease-modifying anti-rheumatic drugs in rheumatoid arthritis.
    Fan J; Jiang T; He D
    Front Immunol; 2023; 14():1189036. PubMed ID: 37841256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DMARDs-Gut Microbiota Feedback: Implications in the Response to Therapy.
    Zaragoza-García O; Castro-Alarcón N; Pérez-Rubio G; Guzmán-Guzmán IP
    Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33114390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with the composition of the gut microbiome in patients with established rheumatoid arthritis and its value for predicting treatment responses.
    Koh JH; Lee EH; Cha KH; Pan CH; Kim D; Kim WU
    Arthritis Res Ther; 2023 Mar; 25(1):32. PubMed ID: 36864473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota and rheumatoid arthritis: From pathogenesis to novel therapeutic opportunities.
    Zhao T; Wei Y; Zhu Y; Xie Z; Hai Q; Li Z; Qin D
    Front Immunol; 2022; 13():1007165. PubMed ID: 36159786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Gut Microbiota in Rheumatoid Arthritis Patients: Disease-Related Dysbiosis and Modifications Induced by Etanercept.
    Picchianti-Diamanti A; Panebianco C; Salemi S; Sorgi ML; Di Rosa R; Tropea A; Sgrulletti M; Salerno G; Terracciano F; D'Amelio R; Laganà B; Pazienza V
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30261687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triggers and regulation: the gut microbiome in rheumatoid arthritis.
    Mahroum N; Seida R; Shoenfeld Y
    Expert Rev Clin Immunol; 2023; 19(12):1449-1456. PubMed ID: 37712213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of microbiome in rheumatoid arthritis treatment.
    Bodkhe R; Balakrishnan B; Taneja V
    Ther Adv Musculoskelet Dis; 2019; 11():1759720X19844632. PubMed ID: 31431810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Troublesome friends within us: the role of gut microbiota on rheumatoid arthritis etiopathogenesis and its clinical and therapeutic relevance.
    Reyes-Castillo Z; Valdés-Miramontes E; Llamas-Covarrubias M; Muñoz-Valle JF
    Clin Exp Med; 2021 Feb; 21(1):1-13. PubMed ID: 32712721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between Gut Microbiota and Immunomodulatory Cells in Rheumatoid Arthritis.
    Xu H; Zhao H; Fan D; Liu M; Cao J; Xia Y; Ju D; Xiao C; Guan Q
    Mediators Inflamm; 2020; 2020():1430605. PubMed ID: 32963490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacomicrobiology of Methotrexate in Rheumatoid Arthritis: Gut Microbiome as Predictor of Therapeutic Response.
    Yan H; Su R; Xue H; Gao C; Li X; Wang C
    Front Immunol; 2021; 12():789334. PubMed ID: 34975886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiota-Medication Interaction in Rheumatic Diseases.
    Zhang L; Chu CQ
    Front Immunol; 2021; 12():796865. PubMed ID: 34925383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Microbiome Detection Technologies and Application in Antirheumatic Drug Design.
    Wu X; Chen X; Lyu X; Zheng H
    Curr Pharm Des; 2021; 27(7):891-899. PubMed ID: 33308114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheumatoid arthritis and the intestinal microbiome: probiotics as a potential therapy.
    Yang Y; Hong Q; Zhang X; Liu Z
    Front Immunol; 2024; 15():1331486. PubMed ID: 38510244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of Gut Microbiota in Inflammatory Arthritis: Highlights and Future Challenges.
    Horta-Baas G; Sandoval-Cabrera A; Romero-Figueroa MDS
    Curr Rheumatol Rep; 2021 Jul; 23(8):67. PubMed ID: 34218340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Levels of IFABP2 and Differences in
    Zaragoza-García O; Castro-Alarcón N; Pérez-Rubio G; Falfán-Valencia R; Briceño O; Navarro-Zarza JE; Parra-Rojas I; Tello M; Guzmán-Guzmán IP
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet, Microbiota, and Gut Permeability-The Unknown Triad in Rheumatoid Arthritis.
    Guerreiro CS; Calado Â; Sousa J; Fonseca JE
    Front Med (Lausanne); 2018; 5():349. PubMed ID: 30619860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between NSAIDs, opioids and the gut microbiota - Future perspectives in the management of inflammation and pain.
    Zádori ZS; Király K; Al-Khrasani M; Gyires K
    Pharmacol Ther; 2023 Jan; 241():108327. PubMed ID: 36473615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut bacteriome, mycobiome and virome alterations in rheumatoid arthritis.
    Dagar S; Singh J; Saini A; Kumar Y; Chhabra S; Minz RW; Rani L
    Front Endocrinol (Lausanne); 2022; 13():1044673. PubMed ID: 36699026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota in pre-clinical rheumatoid arthritis: From pathogenesis to preventing progression.
    Lin L; Zhang K; Xiong Q; Zhang J; Cai B; Huang Z; Yang B; Wei B; Chen J; Niu Q
    J Autoimmun; 2023 Dec; 141():103001. PubMed ID: 36931952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut-joint axis: Gut dysbiosis can contribute to the onset of rheumatoid arthritis
    Romero-Figueroa MDS; Ramírez-Durán N; Montiel-Jarquín AJ; Horta-Baas G
    Front Cell Infect Microbiol; 2023; 13():1092118. PubMed ID: 36779190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.